Advertising

Mobile carries WebMD forward

Mobile carries WebMD forward

By

Smartphones drove network traffic.

AdAge: advertising's penalty box is empty

The Trustworthy Accountability of National Advertisers launched its naming-names initiative in November, but the list is empty.

Five things for pharma marketers to know: Friday, February 20

Five things for pharma marketers to know: Friday, February 20

By

23andMe is back in the DTC game; Sanofi has named its new CEO; drug companies are contemplating a pay-for-performance sales model.

FDA updates DTC ad policy on risk information

FDA updates DTC ad policy on risk information

By

FDA posted a revised draft guidance document on its brief summary and adequate directions for use concerning risk information in DTC print ads to reflect "recent social science research."

OPDP finds many flaws with Luitpold video

OPDP finds many flaws with Luitpold video

By

The list of objections by the Office of Prescription Drug Promotion, which oversees medical advertising, is a familiar one, and includes concerns such as claims that go beyond the approved indication.

Five things for pharma marketers to know: Tuesday, February 10

Five things for pharma marketers to know: Tuesday, February 10

By

FDA's latest guidance says it is ok to reduce the amount of risk information in print ads, Google amplifies the health information it will serve up with searches and HBO's John Oliver takes on pharmaceutical marketing.

Guidemark Health jumpstarts rebrand, brings on big-agency grad

Guidemark Health jumpstarts rebrand, brings on big-agency grad

By

Tina Fascetti is the mid-sized agency's new Chief Creative Officer. CEO Matt Brown (and ICC Lowe alum) tells MM&M the new Guidemark is just getting started.

FDA to study impact of shorter DTC risk list

FDA to study impact of shorter DTC risk list

By

The FDA is looking into whether abbreviated risk information is a good idea for DTC.

Medical Advertising Hall of Fame taps new members

MAHF 2015 Heritage Ad Awards will be given to campaigns for Bentyl, Hytrin and Navane

Ariz. film, entertainment agency adds depth to Fingerpaint

Ariz. film, entertainment agency adds depth to Fingerpaint

By

With the purchase of Olson Communications, the agency aims to serve clients eager for expertise from outside the healthcare industry.

HCB Health lands Alcon AOR

The Austin agency says it beat out FCB, Ogilvy CommonHealth, GSW Worldwide and H4B Chelsea for the work.

The Planning Shop joins Omnicom

The London healthcare brand and research agency will be part of Omnicom's DAS Group.

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

OPDP says phentermine site thin on details

OPDP says phentermine site thin on details

By

The bad-ad watchdog says the promotional website for the weight-loss medication Suprenza leaves out too much information.

FDA examines DTC close up

FDA examines DTC close up

By

The regulator's latest study will use eye-tracking tools.

OPDP takes on sales aid for alcohol drug

OPDP takes on sales aid for alcohol drug

By

The advertising watchdog gave drugmaker Alvogen 15 days to make amends.

Publicis, Facebook ink deal

The Omnicom-Publicis deal may have been scuttled, but the hunger for deals remains.

Takeda admits running bad ads

The company said it used "inappropriate expressions" in promotions of a blood pressure medication.

NABP seeks pharmacy oversight

The National Association of Boards of Pharmacy says about 97% of surveyed pharmacy sites fail to comply with laws.

Raid at Novartis Tokyo

The reason: Diovan.

FDA may ditch some TV ad requirements

A consumer survey will shape the regulator's position.

Google ads target off-limits Canadians

Canada's Office of the Privacy Commissioner says the search giant failed to protect what qualifies as sensitive user information.

New owner to publish MedAdNews biannually

New owner to publish MedAdNews biannually

By

A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.

FTC wants media to be wary of ads

The agency says outlets need to rethink running ads that make false claims.

Japan lodges complaint against Novartis

The Health Ministry alleges Novartis exaggerated advertising for its blood pressure drug Diovan.

The year's most popular stories

The year's most popular stories

Our year-end list captures the 10 that sparked heaviest interest.

Draft legislation has advertisers on edge

Draft legislation has advertisers on edge

By

Lobbying groups say the ad tax draft proposal could wreak havoc throughout the ad industry and its partners, such as publishers and broadcasters, if it were to go through.

Polls highlight chronic disease information needs

Polls highlight chronic disease information needs

By

Chronic disease patients seek online support and information, and show little love for branded websites.

UK, Brazilian ads take top honors at Globals

UK, Brazilian ads take top honors at Globals

An organ-donation campaign with a Brazilian football tie-in, and a UK managed-access company's series of documentary films, took top honors.

Ariad hunkers down

Ariad hunkers down

By

The drugmaker's latest financial plans could power it through mid-2015.

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

Email Newsletters